meta-analysis | Q815382 |
review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Peter Villiger | Q89494992 |
Sven Trelle | Q28360282 | ||
Stephan Reichenbach | Q28360286 | ||
Britta Tendal | Q28360290 | ||
Eveline Nüesch | Q28360292 | ||
Peter Jüni | Q28360295 | ||
P2093 | author name string | Nicky J Welton | |
Simon Wandel | |||
P2860 | cites work | Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial | Q81484755 |
Glucosamine therapy for treating osteoarthritis | Q24244026 | ||
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study | Q24550236 | ||
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial | Q24630475 | ||
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system | Q24647595 | ||
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation | Q28219547 | ||
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | Q28374250 | ||
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study | Q28750315 | ||
Radiological assessment of osteo-arthrosis | Q29614927 | ||
Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 | ||
Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
Interaction revisited: the difference between two estimates | Q29619619 | ||
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial | Q32050561 | ||
Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials | Q33214439 | ||
Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention | Q33397604 | ||
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 | ||
Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study | Q34001775 | ||
Osteoarthritis: new insights. Part 2: treatment approaches. | Q34080887 | ||
Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study | Q34528067 | ||
Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. | Q34552101 | ||
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator | Q34574562 | ||
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose | Q34577442 | ||
Meta-analysis: chondroitin for osteoarthritis of the knee or hip. | Q34619761 | ||
Glucosamine for pain in osteoarthritis: why do trial results differ? | Q34643259 | ||
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. | Q35065178 | ||
Combining scores from different patient reported outcome measures in meta-analyses: when is it justified? | Q35238196 | ||
Osteoarthritis: rational approach to treating the individual | Q36595813 | ||
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis | Q36856022 | ||
Identifying relevant studies for systematic reviews | Q36888457 | ||
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis | Q36942534 | ||
Evaluation of networks of randomized trials | Q36966424 | ||
Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale | Q39379414 | ||
Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial | Q39871697 | ||
Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons | Q40618049 | ||
Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lo | Q40691947 | ||
Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. | Q42276386 | ||
Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis | Q43546528 | ||
Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial | Q46746770 | ||
Bayesian approaches to random-effects meta-analysis: a comparative study. | Q52320769 | ||
Glucosamine sulfate in osteoarthritis of the knee. | Q53017997 | ||
Comparison of the responsiveness of symptomatic outcome measures in knee osteoarthritis. | Q53852143 | ||
The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. | Q55044134 | ||
Chondroitin for Pain in Osteoarthritis | Q57244838 | ||
Variance imputation for overviews of clinical trials with continuous response | Q68186031 | ||
Measuring relevant change: an emerging challenge in rheumatologic clinical trials | Q71970862 | ||
Clinically relevant change and clinically relevant difference in knee osteoarthritis | Q72997464 | ||
Network meta-analysis for indirect treatment comparisons | Q74720205 | ||
Anti-inflammatory activity of chondroitin sulfate | Q77320493 | ||
Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities | Q77588156 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
P433 | issue | sep16 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-inflammatory agent | Q581996 |
carbohydrate | Q11358 | ||
osteoarthritis | Q62736 | ||
patient | Q181600 | ||
meta-analysis | Q815382 | ||
knee osteoarthritis | Q1777118 | ||
placebo | Q269829 | ||
glucosamine | Q32907954 | ||
osteoarthritis susceptibility 5 | Q55999930 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | c4675 | |
P577 | publication date | 2010-09-16 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis | |
P478 | volume | 341 |
Q88733365 | 2017 update of the Turkish League Against Rheumatism (TLAR) evidence-based recommendations for the management of knee osteoarthritis |
Q92155858 | A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis |
Q91802021 | A Novel Application of Buprenorphine Transdermal Patch to Relieve Pain in the Knee Joint of Knee Osteoarthritis Patients: A Retrospective Case-Control Study |
Q34248533 | A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial |
Q38915646 | A comparison of surgical outcomes and complications between hemostatic devices for thyroid surgery: a network meta-analysis |
Q36860248 | A copper sulfate and hydroxylysine treatment regimen for enhancing collagen cross-linking and biomechanical properties in engineered neocartilage |
Q39453934 | A network meta-analysis of the clinical properties of various types of supraglottic airway device in children. |
Q38638647 | A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee |
Q94471960 | A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions |
Q38634272 | Acetaminophen for Chronic Pain: A Systematic Review on Efficacy |
Q37956680 | Are we moving in the right direction with osteoarthritis drug discovery? |
Q35105965 | Attenuation of experimental pain by vibro-tactile stimulation in patients with chronic local or widespread musculoskeletal pain |
Q47789675 | Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial |
Q58798730 | Bayesian Network Meta-Analysis of the Effectiveness of Various Interventions for Nontraumatic Osteonecrosis of the Femoral Head |
Q37565126 | Bayesian network meta-analysis comparing five contemporary treatment strategies for newly diagnosed acute promyelocytic leukaemia |
Q41637822 | Bench to Bedside: Platelet-rich Plasma-How Do We Adequately "Untranslate" Translational "Breakthroughs" in an After-market Setting? |
Q37960493 | Cartilage repair and joint preservation: medical and surgical treatment options |
Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
Q24186473 | Chondroitin for osteoarthritis |
Q37391095 | Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study |
Q34906145 | Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI |
Q39539742 | Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac |
Q36475626 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib |
Q51073709 | Comparative effectiveness of antihypertensive drugs in patients with diabetes. |
Q34380070 | Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis |
Q34188301 | Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate |
Q55431872 | Comparing surgical interventions for intertrochanteric hip fracture by blood loss and operation time: a network meta-analysis. |
Q35642358 | Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis |
Q92384399 | Comparison of the Clinical Effectiveness of Single Versus Multiple Injections of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis |
Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
Q37706220 | D-Glucosamine supplementation extends life span of nematodes and of ageing mice |
Q36691217 | Dietary supplement recommendations by Saskatchewan chiropractors: results of an online survey. |
Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
Q38371965 | Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. |
Q24197534 | Doxycycline for osteoarthritis of the knee or hip |
Q84448818 | Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI |
Q41636872 | Effect of Glucosamine Sulfate on Osteoarthritis in the Cruciate-Deficient Canine Model of Osteoarthritis |
Q37735091 | Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report |
Q50459670 | Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial. |
Q35844016 | Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. |
Q38967030 | Effectiveness of hyaluronic acid and its derivatives on chronic wounds: a systematic review |
Q56942916 | Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis |
Q34519154 | Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis |
Q34500665 | Effectiveness of phototherapy incorporated into an exercise program for osteoarthritis of the knee: study protocol for a randomized controlled trial |
Q42284387 | Effects of dietary supplementation with a standardized aqueous extract of Terminalia chebula fruit (AyuFlex®) on joint mobility, comfort, and functional capacity in healthy overweight subjects: a randomized placebo-controlled clinical trial |
Q35125975 | Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models |
Q88528202 | Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis |
Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
Q28547354 | Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis |
Q41530049 | Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis |
Q28081360 | Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis |
Q26998961 | Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials |
Q92416265 | Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials |
Q41176345 | Efficacy of JOINS on Cartilage Protection in Knee Osteoarthritis: Prospective Randomized Controlled Trial |
Q37331126 | Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial |
Q35942191 | Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials |
Q41623738 | Evaluation of the chondroprotective action of N-acetylglucosamine in a rat experimental osteoarthritis model |
Q37398892 | Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials |
Q38758657 | Feline hip dysplasia: A challenge to recognise and treat. |
Q33874031 | Future directions for the management of pain in osteoarthritis |
Q38362244 | Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants |
Q34396147 | Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens |
Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
Q37708334 | Glucosamine and chondroitin use in canines for osteoarthritis: A review |
Q83520921 | Glucosamine and osteoarthritis: time to quit? |
Q21284705 | Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism |
Q34460174 | Glucosamine supplementation after anterior cruciate ligament reconstruction in athletes: a randomized placebo-controlled trial. |
Q39251211 | Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study |
Q44590836 | Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles |
Q24630093 | Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease |
Q37976026 | Hips, elbows and stifles: common joint diseases in the cat. |
Q43812166 | Hydrotherapy improves pain and function in older women with knee osteoarthritis: a randomized controlled trial. |
Q31139778 | Identifying placebo responders and predictors of response in osteoarthritis: a protocol for individual patient data meta-analysis |
Q26772900 | In vitro models for the study of osteoarthritis |
Q47816389 | Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). |
Q92900560 | Intra-Articular Viscosupplementation for Patients with Hip Osteoarthritis: A Meta-Analysis and Systematic Review |
Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
Q89500060 | Knee joint pain with signs of arthrosis |
Q37164156 | Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II. |
Q35002496 | Lateral wedge insoles for medial knee osteoarthritis: 12 month randomised controlled trial |
Q38669607 | Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study |
Q34334841 | Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis |
Q31046250 | Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative |
Q64924575 | Making 'null effects' informative: statistical techniques and inferential frameworks. |
Q34459643 | Management of Osteoarthritis with Avocado/Soybean Unsaponifiables. |
Q46321517 | Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain |
Q37029967 | Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review |
Q90230702 | Modelling time-course relationships with multiple treatments: Model-based network meta-analysis for continuous summary outcomes |
Q39258614 | Motivations for Botanical Use by Socioeconomically Diverse, Urban Adults: Does Evidence Support Motivation? |
Q24597537 | Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study |
Q90685817 | Network Meta-Analysis of Adjuvant Chemotherapy following Resection of Colorectal Liver Metastases |
Q92464630 | Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis |
Q35602850 | Network meta-analysis of longitudinal data using fractional polynomials |
Q34439173 | No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial |
Q82038017 | No effect of glucosamine sulfate on osteoarthritis in the temporomandibular joints--a randomized, controlled, short-term study |
Q37950849 | Non-surgical management of early knee osteoarthritis |
Q37417111 | Nonoperative treatment approach to knee osteoarthritis in the master athlete |
Q39006999 | Oral glucosamine sulfate supplementation does not induce endoplasmic reticulum stress or activate the unfolded protein response in circulating leukocytes of human subjects. |
Q24194586 | Oral herbal therapies for treating osteoarthritis |
Q24193560 | Oral or transdermal opioids for osteoarthritis of the knee or hip |
Q39217490 | Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model. |
Q41935934 | Osteoarthritis, a disease bridging development and regeneration |
Q45402281 | Outpatient management of knee osteoarthritis |
Q36327832 | Owner-perceived signs and veterinary diagnosis in 50 cases of feline osteoarthritis |
Q35740878 | PURLs: arthritis pain? These supplements provide little relief. |
Q39179495 | Pain Relief for an Osteoarthritic Knee in the Elderly: A Practical Guide |
Q26278817 | Paracetamol for low back pain |
Q91879728 | Paracetamol versus placebo for knee and hip osteoarthritis |
Q86866175 | Pharmacologic treatment of hand-, knee- and hip-osteoarthritis |
Q44728458 | Pharmacological therapy of arthrosis |
Q60959033 | Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline |
Q34636799 | Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities |
Q64888730 | Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual patient data meta-analysis protocol. |
Q35039262 | Prescribing patterns of glucosamine in an older population: a national cohort study. |
Q33845330 | Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. |
Q46676592 | Prevalence and factors affecting glucosamine use in Korea: a survey-based study |
Q38856700 | Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women |
Q91955976 | Reduction of osteoarthritis severity in the temporomandibular joint of rabbits treated with chondroitin sulfate and glucosamine |
Q37230887 | Relative efficacy of different types of exercise for treatment of knee and hip osteoarthritis: protocol for network meta-analysis of randomised controlled trials |
Q31133826 | Relative efficacy of topical non-steroidal anti-inflammatory drugs and topical capsaicin in osteoarthritis: protocol for an individual patient data meta-analysis |
Q34423402 | Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. |
Q48365337 | Risk of ischemic stroke associated with non-steroidal anti-inflammatory drugs and paracetamol: a population-based case-control study. |
Q38421338 | Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. |
Q46175901 | Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial |
Q26861896 | Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials |
Q64245298 | Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
Q92691743 | Scientific Papers and Patents on Substances with Unproven Effects. Part 2 |
Q34573781 | Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study |
Q92627543 | Simultaneous, Delayed and Liver-First Hepatic Resections for Synchronous Colorectal Liver Metastases: A Systematic Review and Network Meta-Analysis |
Q40068056 | Strawberries Improve Pain and Inflammation in Obese Adults with Radiographic Evidence of Knee Osteoarthritis |
Q37454978 | Studies of pain management in osteoarthritis: bedside to policy |
Q36141312 | Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum(®) |
Q57380290 | Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow-up times reported inconsistently: a smoking cessation case-study |
Q33851507 | Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine |
Q38311380 | Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases |
Q47122053 | The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis |
Q35786880 | The Masters Athlete: A Review of Current Exercise and Treatment Recommendations |
Q35871201 | The Microbiome and Musculoskeletal Conditions of Aging: A Review of Evidence for Impact and Potential Therapeutics |
Q39059017 | The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies |
Q43884253 | The network meta-analytic-predictive approach to non-inferiority trials |
Q96350919 | The response-time relationship and covariate effects of acupuncture for chronic pain: a systematic review and model-based longitudinal meta-analysis |
Q36450771 | The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials |
Q30540752 | The use of glucosamine for chronic low back pain: a systematic review of randomised control trials |
Q37858371 | Treatment options for osteoarthritis: considerations for older adults |
Q63352658 | Type 2 diabetes mellitus and osteoarthritis |
Q43201198 | Unusual case of drug-induced cholestasis due to glucosamine and chondroitin sulfate |
Q45748116 | Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. |
Q58704117 | Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers |
Q36570336 | Use of glucosamine and chondroitin in relation to mortality |
Q91867823 | Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature |
Q64933398 | Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. |
Q37868775 | What about supplements for osteoarthritis? A critical and evidenced-based review |
Q42371658 | Which treatment is preferred for advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor in second-line therapy? A meta-analysis comparing immune checkpoint inhibitor, tyrosine kinase inhibitor and chemotherapy |
Q31080416 | Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older |
Q82479710 | [Marketing-based prescribing] |
Q87168539 | [Osteoarthritis: what internists should know] |
Q88336488 | [Pharmacological treatment of osteoarthritis-related pain] |
Q83424504 | [To improve quality healthcare does not imply publicly funding any drug] |
Search more.